Artificial Intelligence, or AI for short, has been one of those buzzwords that's been circulating throughout the healthcare industry. Most recently, it has been widely considered to be extremely beneficial for drug discovery and in clinical trials.
Clinical trials are still the only viable way to bring new medicines and products to market. However, successful clinical trials require participants (subjects), locating, and screening-eligible participants. This can be challenging.
According to an EvaluatePharma study, two-thirds of all drug launches failed to meet pre-launch expectations in sales their first year on the market.
Technology has become an essential part of our lives, whether we like it or not. Various types of technology have directly affected our daily activities; how we communicate and travel, and in this case, how we work.
Selling is hard, there's no arguing that. To meet this challenge head-on, most industries employ the five C's method of sales with great success.
As a leader in the pharmaceutical or medical device industry, you probably spend a fair bit of time being concerned about a potential drug recall or product recall that may never come.
In the age of pharma 3.0, maintaining consistent and effective patient case management across the spectrum is critical to patient adherence, brand trust, and overall treatment success.
Anupam Nandwana | January 9, 2018
Swapan Kumar Manna | May 20, 2018
Avirup Basu | June 7, 2018
Anupam Nandwana | October 6, 2017
Anupam Nandwana | March 8, 2018